23.8 C
Gold Coast
Tuesday, January 18, 2022

Clinical Trial – Psilocybin for Major Depressive Disorder (USA – Multi-site) Phase 2

The purpose of this research is to study the medical and safety effects of a single dose of an investigational drug called psilocybin compared to a placebo in participants with depression.
Ecofibre lab

Clinical Trial – Medicinal CBD for Sleep Disturbances in Healthy Adults (Australia – Multi-Site)

Ecofibre Ltd & Southern Cross University have commenced Australia's largest clinical trial investigating CBD for sleep disturbances.

Clinical Trial – Ibogaine for Opioid-Use Disorder (UK)

Study DMX-IB 201 is a Phase 1/2a study of ibogaine consisting of a randomized, double-blind, placebo-controlled proof of concept stage to demonstrate the efficacy, safety and tolerability of the selected dose in opioid-dependent patients who seek medically supervised opioid withdrawal.

Clinical Trial – Ibogaine for Alcohol Use Disorder (Brazil)

The aim of the present study is to evaluate the safety, tolerability and efficacy of increasing doses of ibogaine in 12 alcoholic patients. Each patient will be hospitalized for 20 days and receive 3 increasing doses of ibogaine.

Clinical Trial – Ibogaine for Methadone Detoxification (Spain)

This phase-II RCT will dose 20 patients from the methadone maintenance program with ibogaine to establish efficacy and safety of ibogaine treatment.
anorexic woman

Clinical Trial – Psilocybin-Assisted Therapy for Females with Anorexia Nervosa (London)

Imperial College London will conduct a clinical trial with psilocybin-assisted therapy in the treatment of anorexia nervosa in adult women.

Clinical Trial – DMT-Assisted Therapy for Healthy Adults and Major Depressive Disorder (London/Manchester)

Small Pharma and Imperial College will conduct a clinical trial into the effects of DMT on Major Depressive Disorder. Both Healthy Volunteers and MDD patients will be included.
psychedelic head

Clinical Trial – Psilocybin-Assisted Therapy for Treatment-Resistant Depression (Australia)

This open-label trial will investigate feasibility and efficacy of psilocybin-assisted psychotherapy for treatment-resistant depression.

Clinical Trial – LSD Microdoses for Creativity & Brain Activity in Healthy Males (NZ)

This study will be a randomised controlled trial of repeated microdoses of LSD under schedules similar to those suggested in the grey literature. 80 healthy male volunteers will be randomised to receive repeated doses of either inactive placebo or LSD (10 µg oral) under double-blind conditions in a parallel groups design.
ibogaine pills

Clinical Trial – Ibogaine in Healthy Adults (UK)

30 volunteers who have tried a hallucinogen will take a single oral dose of Ibogaine in a clinical setting and stay for 6 nights in the clinic.

Must Read

Woman's decolletage shadowed

Navigating Sexual Trauma in Psychedelic Spaces

When sexual boundaries are crossed in therapeutic spaces or people with a history of trauma are not well supported there is a real risk of lasting psychological, emotional, energetic and physical harm being caused to both participants and facilitators/healers.